Why is QMS Medical falling/rising?

As of 03-Sep, QMS Medical Allied Services Ltd is experiencing a price increase, currently at 95.05, reflecting a rise of 2.2 or 2.37%. The stock has shown strong performance in the short term, with a 12.22% increase over the past week and a 21.55% increase over the past month, significantly outperforming the Sensex, which has only seen a 0.01% rise in the same week and a 0.61% rise over the month. Today's trading activity indicates a notable increase in investor participation, with delivery volume rising by 212.87% compared to the 5-day average. Additionally, the stock is trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. The company has demonstrated healthy long-term growth, with operating profit increasing at an annual rate of 30.17%, and its attractive valuation, indicated by a 1.6 Enterprise value to Capital Employed ratio, suggests that it is trading at a discount compared to its peers.
In the broader market context, while QMS Medical has underperformed over the past year with a return of -22.97%, the overall market, represented by the BSE500, has seen a lesser decline of -4.38%. This stark contrast highlights the stock's volatility and challenges in the longer term. Despite this, the recent positive momentum may be attributed to the company's rising profits, which have increased by 19.9% over the past year, and a favorable PEG ratio of 0.8, indicating potential for growth relative to its valuation. However, the flat results reported in June and the significant growth in interest expenses could pose risks that investors need to consider.